CJC-1295 dosage protocols Dosing CJC-1295 correctly requires understanding which version you're using, your specific goals, and how the peptide fits into your broader protocol
Acta Neuropsychiatrica 24(5), 296300.CrossRefGoogle Scholar Krass, M, Volke, A, Rnkorg, K, Wegener, G, Lund, S, Abildgaard, A, Vasar, E and Volke, V (2015) GLP-1 receptor agonists have a sustained stimulatory effect on corticosterone release after chronic treatment
4 (Suppl 1): S83S86
This reveals whether you have insulin resistance that benefits particularly from tirzepatide or retatrutide, whether you have elevated liver fat that benefits from retatrutides glucagon pathway, and whether there are any contraindications we need to address before starting